Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Tennis Champion Caroline Wozniacki and UCB Launch Advantage Hers Campaign

INFORMATION REGLEMENTEE


[09/09/2020 | 07:07]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ekQjp9TTFVchd0-2Bvoqf7EWdUUXm30SIBAVHfDFXx22g-2FMELtYSA=
MLH4okLNpiRkhHmH-2BaJOnW7-2F-2BHbvOG0JZ6m2vsyb_xDPID0vOuylFAU8fv4e60wei4Jxq=
EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2=
F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4o=
pW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUnwB217M-2Fo4FqPFIwdGla9IfmuJNioYi=
JMF0Nv-2F68-2FbyJtI641Ac-2FH3oYQqEUjUD3CWc99qPT8jyHkAR0svcwPA5EGAcGJXf3IvaA=
OwIYPXiOdvkqnWOnJEvgeaDEAxzerOqo9VBTo-2F0DW6IwcPqkShQ-3D

** Tennis Champion Caroline Wozniacki and UCB Launch Advantage Hers Campaig=
n for Women with Chronic Inflammatory Diseases
------------------------------------------------------------

=C2=B7 Grand Slam winner Caroline Wozniacki is the highest-ranking female a=
thlete known to have been diagnosed with rheumatoid arthritis whilst still =
playing professional tennis
=C2=B7 Advantage Hers will equip and empower women around the world living =
with chronic inflammatory diseases, such as rheumatoid arthritis, to take m=
ore active roles in shared decision-making about their care

Brussels, Belgium =E2=80=93 9 September 2020 =E2=80=93 UCB, a global biopha=
rmaceutical company, has partnered with world-renowned tennis champion Caro=
line Wozniacki to launch Advantage Hers (https://u7061146.ct.sendgrid.net/l=
s/click?upn=3D4tNED-2FM8iDZJQyQ53jATUR5nM4D4Fngq12gORsjYD7vnKl2BXk68FWAIR3D=
uxS0XSjCT_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6E=
FaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYe=
uLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEH=
WDcJUn6Q3mYjHKFbhzg8cDI8a9AEdX6kMoc0bcN6Q3UD3HJ50i0rROMUUtrLrbhYSeV4pk7DtKc=
uhyyyh1e1OXavIpwUYclPOw1doG4itM-2FcW4sG23dk5o69tNM-2BOKvnLTtf2JlS50HY6uVqq-=
2B6aZQr4AMiE-3D , a major new global health initiative. Inspired by Carolin=
e=E2=80=99s own journey with rheumatoid arthritis, the campaign will raise =
awareness of the unmet needs of millions of women across the world living w=
ith chronic inflammatory diseases, such as rheumatoid arthritis, axial spon=
dyloarthritis, psoriatic arthritis and psoriasis, and provide information a=
nd support to empower them to take more active roles in their care.=C2=A0

=E2=80=9CI know from experience the difficulties of living day-to-day with =
a chronic disease such as rheumatoid arthritis, as well as the delays there=
can be getting a swift and accurate diagnosis. This is why I am so passion=
ate about being part of Advantage Hers,=E2=80=9D said Caroline Wozniacki. =
=E2=80=9CThrough this new awareness and empowerment campaign, I want to con=
nect with as many women with chronic inflammatory diseases around the world=
as possible, to help inspire, encourage and provide other women like me wi=
th as much support and information as possible. Collectively we can support=
each other in gaining advantage over our conditions =E2=80=93 one small wi=
n at a time.=E2=80=9D

Chronic inflammatory diseases, such as rheumatoid arthritis, axial spondylo=
arthritis, psoriatic arthritis and psoriasis, affect more than 180 million =
people worldwide^1,2,3=C2=A0 approximately half of which are women.^4,5,6=
=C2=A0These chronic conditions can place substantial physical and emotional=
strains on those living with them.^7,8,9,10,11 Symptoms can vary, but incl=
ude chronic pain, constant fatigue, gastrointestinal complications and freq=
uent infections, as well as emotional burdens, such as depression or anxiet=
y, and comorbidities like diabetes and heart disease.^12=C2=A0

The Advantage Hers campaign is underpinned by a necessity to improve the st=
andard of care for women with these chronic inflammatory diseases and the n=
eed to equip them with tools to help them become their own care self-advoca=
tes. Women with these conditions encounter unique challenges and gender dis=
parities that need addressing, including delayed diagnosis in some of the c=
onditions for women^13,14=C2=A0increased physical and mental burdens as com=
pared to men with the same diseases,^7,8,9,11 and unaddressed concerns rela=
ted to family planning and pregnancy. =C2=A0

=E2=80=9CWe are inspired by Caroline=E2=80=99s tenacity and winning mindset=
in the face of her health challenges. We are proud to partner with her on =
this exciting new program and be a part of her rheumatoid arthritis journey=
,=E2=80=9D said Emmanuel Caeymaex, Executive Vice President Immunology Solu=
tions and Head of US, UCB. =E2=80=9CThe Advantage Hers campaign reflects ou=
r commitment to understanding and addressing the unique needs of women with=
these chronic inflammatory diseases around the world, and helping to make =
a meaningful difference to their lives.=E2=80=9D=C2=A0

As part of the program, Caroline will be sharing her rheumatoid arthritis j=
ourney across her social channels and encouraging others to become a part o=
f the conversation by using #AdvantageHers. She also plans to make appearan=
ces at high-profile events to share her story and drive awareness of the un=
met needs of women with these chronic inflammatory diseases.

To get involved, follow Caroline=E2=80=99s journey on her social channels (=
Instagram: @carowozniacki; Twitter: @CaroWozniacki; Facebook: Caroline Wozn=
iacki), using #AdvantageHers. More information and resources on living with=
these chronic inflammatory diseases can be found at: AdvantageHers.com (ht=
tps://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUR5nM4D=
4Fngq12gORsjYD7vnKl2BXk68FWAIR3DuxS0XdtZB_xDPID0vOuylFAU8fv4e60wei4JxqEGBdV=
Wu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c=
9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW6hq=
9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUn8eTHl2YPW8yJqC-2Fpc0oRuFun7v0aKXuMTQe=
CKZA850ZfFS62IJxxYblEbF4fQvnJt533gGb1-2BooawMJuQVFHIV71JIyGimQ07DudNKbQVXsK=
OFk1CIDmtDnVIgCDTQSYWNSdds8-2FuBIVn2UkkU8n2g-3D .=C2=A0

About the Advantage Hers campaign
Advantage Hers is a global campaign designed to highlight the unmet needs a=
nd unique challenges of women living with a particular subset of chronic in=
flammatory diseases, such as rheumatoid arthritis, axial spondyloarthritis,=
psoriatic arthritis and psoriasis. Tennis champion Caroline Wozniacki is s=
haring her journey with rheumatoid arthritis on her social channels =E2=80=
=93 from her initial struggles for a diagnosis, through the adjustments she=
is making in her life right now, to what goals she has for the future =E2=
=80=93 to inspire, encourage and empower other women living with these chro=
nic inflammatory diseases to take more active roles in their care. To learn=
more, please visit the campaign website: AdvantageHers.com (https://u70611=
46.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUR5nM4D4Fngq12gORsj=
YD7vnKl2BXk68FWAIR3DuxS0Xja7T_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8=
sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53x=
rh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PF=
fw3Ac68c6XoauoMssqEHWDcJUn0cRYF27hbQQKR0RI8094PjJs50gBzUC7FHCWvu1H93qHXIvPI=
f6meA0yjtqdF6nbe-2Br69VcAUIc6JsWS1Daaxn6VY4-2Fg2Quyr5nFfyXIe5EnhCbzCTPEyz4l=
LjIJoPKnD1PDgQdqInZsqn5odp1Yls-3D .

About chronic inflammatory diseases, such as rheumatoid arthritis
Chronic inflammation is long-term inflammation =E2=80=93 when the immune sy=
stem recognizes and removes harmful stimuli =E2=80=93 lasting anywhere from=
several months to years.^12 Chronic inflammatory disease is a broad and ev=
olving description for conditions associated with chronic inflammation. UCB=
focuses particularly on rheumatoid arthritis, axial spondyloarthritis, pso=
riatic arthritis and psoriasis.=C2=A0

=C2=B7 Rheumatoid arthritis causes pain and stiffness in the joints;^16=C2=
=A0
=C2=B7 Axial spondyloarthritis (including ankylosing spondylitis and non-ra=
diographic axial spondyloarthritis) causes swelling in the sacroiliac joint=
s or spine, which can lead to lower back pain and stiffness;^17=C2=A0
=C2=B7 Psoriatic arthritis causes swelling, pain, fatigue and stiffness in =
the joints;^18=C2=A0
=C2=B7 Psoriasis causes raised, red, scaly patches on the skin.^19=C2=A0=C2=
=A0

These diseases have a high prevalence in the western world,^1,2,20,21=C2=A0=
particularly in women,^4,5,6 and can lead to permanent joint damage, functi=
onal impairment and an increased risk of depression and anxiety.^11,12

An often-overlooked dimension of these chronic inflammatory diseases are un=
ique challenges and gender disparities that women with these conditions fac=
e. For example, some women experience greater delays than men in receiving =
an accurate diagnosis in some of the conditions, which can affect their dis=
ease outcomes.^13,14 Different chronic inflammatory diseases can also cause=
women to experience greater pain, fatigue,^7 loss of function^11 and stres=
s^8 than men with these conditions. In addition, women living with these ch=
ronic inflammatory diseases may have gaps in their knowledge and unaddresse=
d healthcare concerns, such as family planning, and may not feel empowered =
to ask the right questions to their doctor.^15

About Caroline Wozniacki
Caroline Wozniacki is a 30-year-old former professional tennis player from =
Denmark who was born into a family of athletes; her father =E2=80=93 and te=
nnis coach =E2=80=93 is a former footballer in Poland and Denmark, and her =
mother is a former member of the Polish national volleyball team. Caroline =
began playing tennis at the age of nine and her professional career took of=
f at the age of 15 when she joined the World Tennis Association (WTA) tour,=
one year before she made the junior singles final at the Australian Open.^=
22=C2=A0=C2=A0

Caroline was at the peak of her tennis career in 2018 when she was diagnose=
d with rheumatoid arthritis. She has been a Grand Slam Champion and the wor=
ld=E2=80=99s top ranked female player on the court and is now taking on the=
title of patient advocate =E2=80=93 sharing her personal rheumatoid arthri=
tis journey with the world. Having retired from her tennis career in Januar=
y 2020, Caroline plans to focus on other things, including advancing her st=
udies, supporting women living with chronic inflammatory diseases, such as =
rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis and psor=
iasis, and to consider building a family.=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases in immunol=
ogy and neurology. With 7,500 people in approximately 40 countries, the com=
pany generated revenue of =E2=82=AC 4.6 billion in 2018. UCB is listed on E=
uronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news

For further information, UCB:=C2=A0

Communications Lead
Andrea Levin Christopher,
Immunology Communications, UCB
T +1.404.483.7329, andrea.christopher@ucb.com=C2=A0

Corporate Communications
Laurent Schots=C2=A0
Media Relations, UCB =C2=A0
T+32.2.559.92.64 =C2=A0Laurent.schots@ucb.com=C2=A0

Forward looking statements =E2=80=93 UCB=C2=A0
This press release contains forward-looking statements based on current pla=
ns, estimates and beliefs of management. All statements, other than stateme=
nts of historical fact, are statements that could be deemed forward-looking=
statements, including estimates of revenues, operating margins, capital ex=
penditures, cash, other financial information, expected legal, political, r=
egulatory or clinical results and other such estimates and results. By thei=
r nature, such forward-looking statements are not guarantees of future perf=
ormance and are subject to risks, uncertainties and assumptions which could=
cause actual results to differ materially from those that may be implied b=
y such forward-looking statements contained in this press release. Importan=
t factors that could result in such differences include: changes in general=
economic, business and competitive conditions, the inability to obtain nec=
essary regulatory approvals or to obtain them on acceptable terms, costs as=
sociated with research and development, changes in the prospects for produc=
ts in the pipeline or under development by UCB, effects of future judicial =
decisions or governmental investigations, product liability claims, challen=
ges to patent protection for products or product candidates, changes in law=
s or regulations, exchange rate fluctuations, changes or uncertainties in t=
ax laws or the administration of such laws and hiring and retention of its =
employees. UCB is providing this information as of the date of this press r=
elease and expressly disclaims any duty to update any information contained=
in this press release, either to confirm the actual results or to report a=
change in its expectations.
=C2=A0
There is no guarantee that new product candidates in the pipeline will prog=
ress to product approval or that new indications for existing products will=
be developed and approved. Products or potential products which are the su=
bject of partnerships, joint ventures or licensing collaborations may be su=
bject to differences between the partners. Also, UCB or others could discov=
er safety, side effects or manufacturing problems with its products after t=
hey are marketed. Moreover, sales may be impacted by international and dome=
stic trends toward managed care and health care cost containment and the re=
imbursement policies imposed by third-party payers as well as legislation a=
ffecting biopharmaceutical pricing and reimbursement.

References

1. World Health Organization. The Global Burden of Disease 2004 Update. Ava=
ilable at: https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQy=
Q53jATUTmS7bNGmvXKDZT54lZi2FYPEWQokSqOos1EhJ7hCoxKrU8XmLoBX1Xy9UfSA2Ii3CisU=
TLhEywdbmPV2EtJ5gPBfHKxO4wKMGcghK4rxKK-2Fy8zz_xDPID0vOuylFAU8fv4e60wei4JxqE=
GBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F=
2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4op=
W6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUnw2fkls4e-2Fg3MaxxXsKWJem1yfowgYt3=
bARGLP6wls-2FBhXD9vg3ya8nlt1lCU9H0uYe8eKPNzzHPIMF1orXZPXE0yGYJ0heROap08ZB3-=
2FR-2FOmel6-2BRcvI-2FtyvtQsJWqEXRsTUaz-2BOEJyPxVNuPIcEGw-3D Accessed Januar=
y 2020.
2. National Psoriasis Foundation. Statistics. Available at: https://u706114=
6.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUR99VTZcqUN3eugCU-2B=
02-2BG1-2BTf3suX3OEusfyLsZstmHiehV6SNVLtdCeDRVb0OiAw-3D-3DPj4l_xDPID0vOuylF=
AU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2=
FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOICJJA0=
GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUnzmKb0-2FlxUW18l6=
p-2BUwfYgKCVlW5iTaIyfht-2FY9YCKMkME64ND6snpkhQSkhhMSIJbElg761yBjSu2b5bRGrPU=
2U93rF8ZDvyU75hAxX0ZXATgyPzaGDQy-2Fj7tiNO7CGovD6kGiJmus05tGmWfTFziw-3D Acce=
ssed January 2020.
3. Reveille JD, et al. Prevalence of axial spondylarthritis in the United S=
tates: estimates from a cross-sectional survey. Arthritis Care Res (Hoboken=
). 2012;64(6):905-910.
4. Myasoedova E, Croswon CS, Kremers HM, et al. Is the incidence of rheumat=
oid arthritis rising?: Results from Olmsted County, Minnesota, 1955=E2=80=
=932007. Arthritis Rheum. 2010;62(6):1576-1582.
5. Boehncke WH, =C2=A0Sch=C3=B6n MP. Psoriasis. The Lancet. 2015;386(9997):=
983-994.
6. Scotti L, Franchi M, Marchesoni A, et al. Prevalence and incidence of ps=
oriatic arthritis: A systematic review and meta-analysis. Semin Arthritis R=
heum. 2018;48(1):28-34.
7. Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender Differen=
ces in Axial Spondyloarthritis: Women Are Not So Lucky. Curr Rheumatol Rep.=
2018;20(6):35.
8. LEO Innovation Lab and The Happiness Research Institute. World Psoriasis=
Happiness Report October 2017. Available online at: https://u7061146.ct.se=
ndgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUfWs8zasrXqKT5Nr7kAoaeLFCSM=
2YlV9MIAlbnIbpy8rQGP9QLFPpXxaIhQ82PiBHj05yEjmcVlMy6c9Rw5AF-2BfPCamt4I-2Fp16=
2ylmyOjTOgBFMhyK9EZXnZQZkC2mw-2Blw-3D-3DzLB7_xDPID0vOuylFAU8fv4e60wei4JxqEG=
BdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2=
X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW=
6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUn7jDjd9D27WwpoVBHKQxjsIa5Jlz8x4d2-2=
FLHUxxcwtkFt0bod8lrcmjGLeYdiYW1RHB5i6sz7frlcDjYnX5Qe9-2BfGNP2uXuvYRamblydJx=
2KxuQXNZLiECrc7-2BC6u2bV-2FRo9p7iABXPCuVw29BBCUUA-3D Last accessed January =
2020.
9. Tournadre A, Pereira B, Lhoste A, et al. Differences Between Women and M=
en With Recent=E2=80=90Onset Axial Spondyloarthritis: Results From a Prospe=
ctive Multicenter French Cohort. Arthritis Care Res (Hoboken). 2013;65(9):1=
482-1489.
10. Mancuso CA, Rincon M, et al. Psychosocial variables and fatigue: a long=
itudinal study comparing individuals with rheumatoid arthritis and healthy =
controls. J Rheumatol. 2006;33(8):1496-1502.
11. Reddy S, Scher J, Swearingen C, et al. SAT0411 Gender Differences in Di=
sease Activity in A Psoriatic Arthritis Routine Care Cohort. Annals of the =
Rheumatic Diseases 2014;73:743-744.
12. Pahwa R, Jialal I. Chronic Inflammation. StatPearls Publishing. Availab=
le at: https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53j=
ATUexkZ-2F-2FvyQ4bknTD8g1avPagNHrBHNLZm-2Fw7-2Bb90Iu-2FsUawpkkogKvV3Jrm1-2B=
MiXBQ-3D-3Dox5c_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0K=
xvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1Nfh=
B5hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6Xoauo=
MssqEHWDcJUn9Ak1g7Dg3WgzuC7ZbRalANo6qcVjiOdw2UXNlbXOBmSeyZuKP6CwRQhGaMIIZ0b=
4nrREU7fJumo76SlGsagnEYvb6Qmo6Kh9xgnE3K-2FO69Q-2Fn5Q-2Bi-2F8IEeYbGqCm5C4ICW=
6jl31PHNDRXQSh-2FgsPu4-3D Accessed January 2020.=C2=A0
13. Osterhaus JT, Purcaru O. Discriminant validity, responsiveness and reli=
ability of the arthritis-specific Work Productivity Survey assessing workpl=
ace and household productivity within and outside the home in patients with=
axial spondyloarthritis, including nonradiographic axial spondyloarthritis=
and ankylosing spondylitis. Arthritis Res Ther. 2014;16(4):R164.
14. Slobodin G, Reyhan I, Avshovich N, et al. Recently diagnosed axial spon=
dyloarthritis: gender differences and factors related to delay in diagnosis=
. Clin Rheumatol. 2011;30(8):1075-80.
15. Tincani A, Taylor P, Fischer-Betz R, et al. FRI0693 Fears and misconcep=
tions of women with chronic rheumatic diseases on their journey to motherho=
od. Annals of the Rheumatic Diseases. 2018;77(2):866.
16. National Rheumatoid Arthritis Society. What is RA? Available at: https:=
//u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUUmrPSjbugw=
4hc1IAacoo5N1r8VRAoASuMDrZdxQ6pMHqgy6V13flOwfc-2BwxNl55Jg-3D-3DVnO0_xDPID0v=
OuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52=
Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOI=
CJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUn2qTtGZKUnI-=
2BRCVdcXoLK8TWnq5CmcdAsi-2Fm9dQGEhFCECqy-2FXMpEwtZcupGAHwgFgqtgLs57iawpcCwF=
8YJYFFdlxR9eLaY2aFxvUvwPjXhluXnPEz4l5yT-2BGW9yVGFqM8rMYa0jgItSm38SOz38Oc-3D=
Accessed April 2020.=C2=A0
17. National National Axial Spondyloarthritis Society. What is axial SpA (A=
S)? Available at: https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM=
8iDZJQyQ53jATUXuwMJ67xTCX3Huy3hU7wI3E0ubEEfCbZ8qla26EX5ZAFBZb_xDPID0vOuylFA=
U8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2F=
OeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOICJJA0G=
yWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUn9VKoSWmCiZK8z5LeA=
FFPb56ysAB14-2F6ScGVACHOVCv6tYd3Uzb6c9Vdxf3CXOYyw8N3N-2FKCbz4TaBFaxd68NEQmg=
W-2BSpUw1WnlXa-2BPOh7uUMoVtEyGZ-2Frrd3VsqkWNbe2tXlh5O0jF786V2KVW9ME0-3D Acc=
essed April 2020.=C2=A0
18. National Psoriasis Foundation. About Psoriatic Arthritis. Available at:=
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUR99=
VTZcqUN3eugCU-2B02-2BG1-2FphU67VMYIap-2FzY6KCDowOLkfW73PXjpRLN7qnOE6Lw-3D-3=
DjftR_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZq=
ddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBt=
jGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJ=
Un9j4dOCSBQ-2BszuasRHR2ilnTta8elIko4E8ysFrC0UUMPsFNWHEnZk7GOVUYFBvcxqZ7kU6A=
LNm9BDkQMH0ji1OUkSiQuCpKw69gJSBzrTlZ6gyKetNhFeoZZ07lUmrfZmXlEsqflTSeIncABPK=
CVsY-3D Accessed April 2020.=C2=A0
19. National Psoriasis Foundation. About Psoriasis. Available at: https://u=
7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUR99VTZcqUN3eu=
gCU-2B02-2BG3-2BMV12ThQqt0ktJsMZah4K3FqY6CpCDjEgtcFdhbm94A-3D-3Dddbe_xDPID0=
vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB5=
2Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMO=
ICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUn8vo8GnYQme=
D06FtpbdZUXbXtwFKI6Pe7K0Qj5KtRQOUsYmFmRoboA00h8iUivO5w-2BQbGjbDjdZKQ4IuzC9b=
MbRPuWBsVPZWW692Ea3JaYSFujTQC5EEfuqmKjVZHn9UpYRBG4GdM0MBorKNrTdeN4M-3D Acce=
ssed April 2020.=C2=A0
20. World Health Organization. Chronic diseases and health promotion. Avail=
able at: https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ5=
3jATUYSNAz46Y7utwoimWFv7B-2BEdU-2FHW0fymnGBXRmM5GFOmSeO6x1Yc-2FHY9-2FEKGevB=
Jhg-3D-3D6azO_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0Kxv=
Ps6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5=
hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMs=
sqEHWDcJUn1BqZuMyWDPZMvLELgBDpmN73-2BB-2Bceh0Olel-2BrFdLvfkcs4YvVeH2X0mkzqT=
xU0nCniVRralVNF36rnt8Q9HUaQiB6H1HVyV-2BPurjBXuLbdUdqZ9apAnPga-2Bf3TAtRFq2Mc=
h7ZI-2FpkFb9d70u5wjL-2Fg-3D Accessed January 2020.
21. The European League Against Rheumatism (EULAR). 10 things you should kn=
ow about rheumatic diseases. Available online at: https://u7061146.ct.sendg=
rid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUTq9akMGSiylBiJISZk2TrIgj-2FnE=
GLXXZDJmjwkHg9oB95F3fbkT8y-2BLnY-2F5yzZ1J2bpRaWEkuYNAm-2FXxGK5aUw-3D6HWc_xD=
PID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZ=
lGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6R=
XPMOICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUnynnDwv=
G77U9QmM0y4QScE1JWns0iBUxeA-2Bk0uHY23aJnVbzm30rjZKdzHA3u-2Bfo5ypj4e0vmMYGs9=
VcA16MBOQP-2BINRHLq6m-2BrRYb6tHYXlWNUIy4-2F9ZQPJ7E8hMEhbhuVE7z2DWoWwDsACgXV=
SCtY-3D Accessed January 2020.
22. Caroline Wozniacki. Profile. Available at: https://u7061146.ct.sendgrid=
.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUSC-2FcCjsgHyJYUF-2BzCSjeKp79HLd2=
iOK0ApdBsDr66-2F6X8Kb_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL8=
6bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFX=
qM1NfhB5hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c=
6XoauoMssqEHWDcJUn1w6GWDwGfhzNsmSVKSjOn1y7WkPppD5oSDXDzWwGpWxoHG4XQM523Mghd=
kjzoKgu1iKinltIvqy2eLaDt4cqfCznvYxdKfzXlosKAmikISl9t-2BHdjeCBBkWu8vk7HZ8kl9=
TtnW72NpsMTsnuXJzXEk-3D Accessed January 2020.=C2=A0

GenericFile
Advantage Hers Press Release EN FINAL (https://u7061146.ct.sendgrid.net/ls/=
click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekQjp9TTFVchd0-2=
Bvoqf7EWdM6h9WJkIKGjql3-2BagnN6HsZ-2BRBk-2Bx1mv3RaVamA1SMY-3DxVVF_xDPID0vOu=
ylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zl=
f-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB5hmYeuLBtjGl-2F6RXPMOICJ=
JA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoMssqEHWDcJUn5KWHIAcZOarxq=
4oXjFxB-2BrfIhPwJFxzouSUluJavfa9W-2Bja-2BF3ttM8XMypdkLVSFDI8SL3sfEHfne7fYI-=
2BXOW3-2BHBtOaS6zTiRfnhEGsAQ9RJ8M58ZOBcRIydYz7FbHwnyug-2FA06eUDBRLRV1nyPwU-=
3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXnLkdNnrFLhnHZbm8FZqhDd8-2B-2BXM=
vbNkWclnbtVKXtKKBdOuXLkZVz-2FK8Im6M1BUgrxkmRZggv03VpkxCOtlrhKZ7P0XQd7Pale2o=
ZCznTbk-3DbsEl_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0Kx=
vPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbPxqL53xrh5GQqFXqM1NfhB=
5hmYeuLBtjGl-2F6RXPMOICJJA0GyWNiRtFDRmBzk4opW6hq9XwQyyVTC3PFfw3Ac68c6XoauoM=
ssqEHWDcJUn-2F-2FUKf20xjvQgb6B2Zcv2pWs4xmYTf51BmF5pQcj07xvuJgV7FJEQAmVHsMqK=
MnvN-2BJaO8-2BdWSpueUnVc9iwOHUntUZ89AaJdQcu0EQJ-2FvvdXLLLDOpP23MCKGMFeJOW3i=
8oD-2FmShVVW7u1bm2pOE8E-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=